Phl p 6
Summary
Phl p 6 is a major allergen from timothy grass (Phleum pratense) pollen, belonging to group 5/6 of grass pollen allergens that are found only in Pooideae species. It is a non-glycosylated peptide with cross-reactivity restricted to grass pollen allergens of group 5/6. Therefore, Phl p 6 is a marker of genuine sensitization to grass pollen
Epidemiology
Worldwide distribution
Timothy grass has a widespread distribution in the temperate climate and is often the predominant grass pollen in such European and Asian regions, less so in Australia.
Phl p 6 was identified as a major allergen of timothy grass pollen, binding IgE from 75% of 171 grass-allergic patients. In grass pollen allergic patients, sensitization to Phl p 6 is less prevalent than to Phl p 1 and Phl p 5, and overall similar to that of Phl p 2 and Phl p 4. Reported prevalence of Phl p 6 sensitization varies from 44% to almost 90% in different cohorts of adult or pediatric grass pollen allergic patients. In an unselected population of 23,077 consecutive Italian subjects with a suspicion of airborne or food allergy, the prevalence of IgE sensitization to Phl p 6 was 13.6%.
The Swedish birth cohort BAMSE provided data in general population. Sensitization to Phl p 6 was the fourth most frequent among timothy grass allergens, detected in 0.3% of 763 pediatric subjects at the age of 4 years, in 2.8% at age 8, and 10.4% at age 16.
Apparent monosensitization to Phl p 6 is infrequent.
Clinical Relevance
Detailed information regarding timothy grass pollen is available in the whole allergen section. Timothy grass pollen induces allergic rhinitis (AR), allergic rhinoconjunctivitis, and exacerbates asthma in sensitized individuals. There is a high degree of cross-reactivity between timothy grass and other grass pollens.
Disease severity and prediction
Detectable IgE sensitization to Phl p 6 is usually found in grass allergic patients, in association with other major allergens, but seldom in sensitized subjects without a history of grass pollinosis. In the birth cohort BAMSE, Phl p 6 sensitization at age 8 in subjects without grass allergy symptoms conferred an adjusted odds ratio of 5.1 for developing grass pollen AR by the age of 16. However, due to the rare occurrence of Phl p 6 sensitization at age 8, this odds ratio did not reach statistical significance. Finally, apparent monosensitization to Phl p 6, reported in the same cohort, was found in a subject without a history of grass pollinosis and without skin reactivity to timothy grass pollen extract of whole allergen.
In an Italian multicenter cohort of children with seasonal allergy, 93% of whom were sensitized to timothy grass at baseline, follow-up data after 6 years did not evidence a predictive value of Phl p 6 sensitization by itself for the type, severity, remission, or persistence of allergic symptoms, in line with previous literature.
Phl p 6 sensitization in the context of the grass pollen molecular allergen profile is a frequent finding, reported in 72% of grass pollen allergic children, but its diagnostic and prognostic relevance has not been established yet.
Cross-reactive molecules
Clinically significant cross-reactivity of Phl p 6 is observed only with related grass allergens, namely group 5 (e.g., Phl p 5) and group 6. It was suggested that IgE directed to group 5 allergens from grass pollens devoid of group 6 molecules, such as Lolium multiflorum, efficiently binds Phl p 6 in vitro
Diagnostics
Disease Severity
Sensitization to Phl p 6 has been associated with more complex sensitization profiles, hence with a later phase of the natural history of sensitization to grass pollen allergens and a higher risk for symptomatic grass pollinosis.
Cross-Reactivity
Phl p 6 cross-reacts with similar proteins from other temperate and subtropical grass species, making it a suitable biomarker of sensitization to grass allergens group 6. In grass allergic Brazilian subjects, who are exposed predominantly to Lolium multiflorum and Cynodon dactylon but not to Phleum pratense, the prevalence of sensitization to microarrayed Phl p 6 was 45%.
AIT Prescription
Phl p 1 and Phl p 5, but not Phl p 6, which is cross-reactive with Phl p 5, are usually employed as biomarkers when grass pollen allergen immunotherapy is considered. Phl p 6 is a relevant allergen for grass AIT in association with Phl p 1, Phl p 5, and Phl p 2, and was included in peptide-based grass allergy preparations for AIT, demonstrating clinical safety and efficacity.
Exposure
The main route of exposure is through inhalation of timothy grass pollen, and P-particles released from the surface of pollen grass pollen
Prevention And Therapy
Experimental trials
Phl p 6 induces skin reactivity, in vitro histamine degranulation, and was identified as a relevant molecule for allergen immunotherapy of grass pollinosis.
References
- Davies JM MP, Schmid J. . Matricardi PM et al. EAACI Molecular Allergology User’s Guide. Pediatr Allergy Immunol 2016(27):1-250.
- Davies JM. Grass pollen allergens globally: the contribution of subtropical grasses to burden of allergic respiratory diseases. Clin Exp Allergy. 2014;44(6):790-801.
- Andersson K LJ. Characteristics and immunobiology of grass pollen allergens. Int Arch Allergy Immunol. 2003(87):87-107.
- Vrtala S FS, Grote M, Vangelista L, Pastore A, Sperr WR, et al. Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from Timothy grass (Phleum pratense) pollen. J Immunol 1999(163):5489-96.
- Tripodi S, Frediani T, Lucarelli S, Macri F, Pingitore G, Di Rienzo Businco A, et al. Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: implications for specific immunotherapy. J Allergy Clin Immunol. 2012;129(3):834-9 e8.
- Rossi RE, Monasterolo G, Prina P, Coco G, Operti D, Rossi L. IgE profiles of Bermuda grass pollen sensitised patients evaluated by Phleum pratense allergens Phl P 1, 2, 4, 5, 6 , 7, 11, 12. Allergol Int. 2008;57(2):157-64.
- Scala E, Alessandri C, Bernardi ML, Ferrara R, Palazzo P, Pomponi D, et al. Cross-sectional survey on immunoglobulin E reactivity in 23,077 subjects using an allergenic molecule-based microarray detection system. Clin Exp Allergy. 2010;40(6):911-21.
- Westman M, Aberg K, Apostolovic D, Lupinek C, Gattinger P, Mittermann I, et al. Sensitization to grass pollen allergen molecules in a birth cohort-natural Phl p 4 as an early indicator of grass pollen allergy. J Allergy Clin Immunol. 2020;145(4):1174-81 e6.
- Hatzler L, Panetta V, Lau S, Wagner P, Bergmann RL, Illi S, et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol. 2012;130(4):894-901 e5.
- Cipriani F, Tripodi S, Panetta V, Perna S, Potapova E, Dondi A, et al. Early molecular biomarkers predicting the evolution of allergic rhinitis and its comorbidities: A longitudinal multicenter study of a patient cohort. Pediatr Allergy Immunol. 2019;30(3):325-34.
- Cipriani F, Mastrorilli C, Tripodi S, Ricci G, Perna S, Panetta V, et al. Diagnostic relevance of IgE sensitization profiles to eight recombinant Phleum pratense molecules. Allergy. 2018;73(3):673-82.
- Moreira PF, Gangl K, Vieira Fde A, Ynoue LH, Linhart B, Flicker S, et al. Allergen Microarray Indicates Pooideae Sensitization in Brazilian Grass Pollen Allergic Patients. PLoS One. 2015;10(6):e0128402.
- http://www.allergen.org. 2021 [August 15th, 2021].
- Focke-Tejkl M, Weber M, Niespodziana K, Neubauer A, Huber H, Henning R, et al. Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy. J Allergy Clin Immunol. 2015;135(5):1207-7 e1-11.
- Eckl-Dorna J, Weber M, Stanek V, Linhart B, Ristl R, Waltl EE, et al. Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG4 response. EBioMedicine. 2019;50:421-32.